Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Company is well positioned following positive FDA Type B meeting outcome, fully enrolled Phase 2 trial for its lead clinical program, and recent $5 million public offering, as commercial operation ...
Diet plays a big role in colon cancer prevention and regularly choosing certain foods, like cruciferous vegetables, may help ...
Detailed price information for Arcutis Biotherapeutics Inc (ARQT-Q) from The Globe and Mail including charting and trades.
The 2026 Improving Musculoskeletal Patient Care Through Outcomes Research (IMPACT) Award was presented to Kevin ...
Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.
Physical exertion combined with deep concentration can severely slow down human reaction times. A recent trial reveals that ...
Magnesium is trending. Here's why it could be worth your time ...
After adjusting for demographics and comorbidities, early mAFP use was associated with significantly higher odds of in-hospital mortality (Adjusted Odds Ratio [aOR] 2.31). Early device placement was ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 11:10 AM ESTCompany ParticipantsJan Mikkelsen - President, CEO, ...
An ongoing Phase III trial aims to further evaluate the drug's clinical efficacy in reducing seizures and affecting behavior and cognition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results